Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) Treatment

Understanding CP/CPPS

CP/CPPS is characterized by pain in the perineum, suprapubic region, testicles, or tip of the penis, often exacerbated by urination or ejaculation, and accompanied by urinary symptoms including frequency, urgency, and sense of incomplete emptying, as reported by the American Urological Association 1, 2
The clinical characteristics of CP/CPPS are very similar to those of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), with some men having symptoms that meet criteria for both conditions, according to the American Urological Association 1, 2, 3

Manual physical therapy techniques, including resolving pelvic, abdominal and/or hip muscular trigger points, lengthening muscle contractures, and releasing painful scars, should be offered to patients with pelvic floor tenderness, as recommended by the American Urological Association 4
Patients should be encouraged to implement stress management practices, such as meditation and imagery techniques, to improve coping techniques and manage stress-induced symptom exacerbations, as suggested by the American Urological Association 5
For patients with overlapping IC/BPS symptoms, oral medications like amitriptyline, cimetidine, and hydroxyzine may be effective, with amitriptyline started at low doses (10 mg) and titrated gradually to 75-100 mg if tolerated, as recommended by the American Urological Association 5, 6

Initial assessment should include evaluating predominant symptom domain (pain, urinary symptoms, or both) and assessing for pelvic floor tenderness, as recommended by the American Urological Association 4
Rule out active infection with urinalysis and culture, as suggested by the American Urological Association 7

A multimodal pain management approach, including non-opioid alternatives, is preferred for pain management, with opioids used judiciously, as recommended by the American Urological Association 6
No single treatment reliably benefits most patients, and treatment response is highly variable between individuals, highlighting the need for personalized treatment plans, as noted by the American Urological Association 8